Strategic planning in London: the rise and fall of the primary road networkHART D. A.1976Book

Evidence that the elevated levels of proteinase activity in the plasma of melanoma-bearing mice may be of host originHART, D. A.Haemostasis. 1986, Vol 16, Num 1, pp 34-42, issn 0301-0147Article

Increased sensitivity of Corynebacterium parvum-treated mice to toxic effects of indomethacin and lipopolysaccharideHART, D. A.Infection and immunity. 1985, Vol 47, Num 2, pp 408-414, issn 0019-9567Article

Augmentation of lithium-induced polydipsia in Cornebacterium parvum-PER treated mice : characterization of the response in C57BL/6 miceHART, D. A.Journal of trace and microprobe techniques. 1999, Vol 17, Num 3, pp 379-395, issn 0733-4680Article

Steroids and tuftsin fail to prevent the induction of altered plasma proteinase homeostasis in mice bearing the B16 melanoma or treated with C. parvumHART, D. A.International journal of immunopharmacology. 1987, Vol 9, Num 6, pp 669-674, issn 0192-0561Article

Evidence that LiCl enhancement of the survival of NZB/W lupus mice is not mediated by alpha-melanocyte stimulating hormoneHART, D. A.Journal of trace and microprobe techniques. 1998, Vol 16, Num 1, pp 111-118, issn 0733-4680Article

Indomethacin induces the suppression of plasma neutral proteinase activity in mice: possible relationship to efficacy as an antiinflammatory drug and induction of alterations in the immune systemHART, D. A.Journal of clinical & laboratory immunology. 1986, Vol 20, Num 4, pp 199-205, issn 0141-2760Article

Lithium potentiates antigen-dependent stimulation of lymphocytes only under suboptimal conditionsHART, D. A.International journal of immunopharmacology. 1988, Vol 10, Num 2, pp 153-160, issn 0192-0561Article

Plasminogen activators and their inhibitors: regulators of extracellular proteolysis and cell functionHART, D. A; REHEMTULLA, A.Comparative biochemistry and physiology. B. Comparative biochemistry. 1988, Vol 90, Num 4, pp 691-708, issn 0305-0491Article

Modulation of plasminogen activator and plasminogen activator inhibitor expression in the human U373 glioblastoma/astrocytoma cell line by inflammatory mediatorsMURPHY, P; HART, D. A.Experimental cell research. 1992, Vol 198, Num 1, pp 93-100, issn 0014-4827Article

Differences between the F10, BL6 and F1 sublines of the B16 melanoma in the enhancement of plasminogen activator and plasminogen activator inhibiter secretion by phorbol myristate acetateHART, D. A; SMITH, R.Cancer letters. 1987, Vol 35, Num 1, pp 27-38, issn 0304-3835Article

The regional planning processGILLINGWATER, D; HART, D. A.1978, 197 p., isbn 0-566-00130-6Book

Formation of stable complexes between urokinase and a human urinary componentCIEPLAK, W; HART, D. A.Thrombosis and haemostasis. 1985, Vol 53, Num 1, pp 36-41, issn 0340-6245Article

Elevated serum soluble CD200 and CD200R as surrogate markers of bone loss under bed rest conditionsKOS, O; HUGHSON, R. L; GORCZYNSKI, R. M et al.Bone (New York, NY). 2014, Vol 60, pp 33-40, issn 8756-3282, 8 p.Article

Gene intervention in ligament and tendon: current status, challenges, future directionsHILDEBRAND, K. A; FRANK, C. B; HART, D. A et al.Gene therapy (Basingstoke). 2004, Vol 11, Num 4, pp 368-378, issn 0969-7128, 11 p.Article

Resistance to lithium-induced apoptosis in a lithium tolerant clone of HL-60 promyelocytesMATSEBATLELA, T. M; MOGODIRI, R. K; HART, D. A et al.Journal of trace and microprobe techniques. 2000, Vol 18, Num 1, pp 163-170, issn 0733-4680Article

Antibodies to fibrin bound tissue type plasminogen activator in systemic sclerosisFRITZLER, M. J; HART, D. A; WILSON, D et al.Journal of rheumatology. 1995, Vol 22, Num 9, pp 1688-1693, issn 0315-162XConference Paper

Effect of retinoic acid on human neuroblastoma: correlation between morphological differentiation and changes in plasminogen activator and inhibitor activityBENJAMIN, L. A; MCGARRY, R. C; HART, D. A et al.Cancer chemotherapy and pharmacology. 1989, Vol 25, Num 1, pp 25-31, issn 0344-5704Article

Lithium chloride enhances survival of NZB/W lupus mice : influence of melatonin and timing of treatmentLENZ, S. P; IZUI, S; BENEDIKTSSON, H et al.International journal of immunopharmacology. 1995, Vol 17, Num 7, pp 581-592, issn 0192-0561Article

Human urokinase, a serine proteinase, potentiates the in-vitro growth of micro-organisms which commonly infect burn patientsHART, D. A; WOODS, D. E.Journal of medical microbiology. 1994, Vol 41, Num 4, pp 264-271, issn 0022-2615Article

Characterization of the plasminogen activators and plasminogen activator inhibitors expressed by cells isolated from rabbit ligament and synovial tissues : evidence for unique cell populationsMURPHY, P. G; FRANK, C. B; HART, D. A et al.Experimental cell research. 1993, Vol 205, Num 1, pp 16-24, issn 0014-4827Article

Human HuH-7 hepatoma cells express urokinas and plasminogen activator inhibitor0-1 : identification, characterization and regulation by inflammatory mediatorsARNDT, A; MURPHY, P; HART, D. A et al.Biochimica et biophysica acta. Molecular basis of disease. 1992, Vol 1138, Num 2, pp 149-156Article

Treatment of mice with indomethacin leads to the appearance of a 125000 dalton plasma protein with the characteristics of an acute phase reactantHART, D. A; MANNERFELDT, J; BABINS, E et al.Journal of clinical & laboratory immunology. 1987, Vol 23, Num 2, pp 83-90, issn 0141-2760Article

Species differences in the detection of high molecular weight urinary plasminogen activatorsHART, D. A; REHEMTULLA, A; BABINS, E. M et al.Comparative biochemistry and physiology. B. Comparative biochemistry. 1986, Vol 84, Num 3, pp 287-293, issn 0305-0491Article

Estrogen receptor-related receptor-a (ERR-α) is dysregulated in inflammatory arthritisBONNELYE, E; LAURIN, N; JURDIC, P et al.Rheumatology (Oxford. Print). 2008, Vol 47, Num 12, pp 1785-1791, issn 1462-0324, 7 p.Article